Sunzen Biotech Berhad (KLSE: SUNZEN)
Malaysia
· Delayed Price · Currency is MYR 0.315
0.00 (0.00%)
At close: Dec 20, 2024
Sunzen Biotech Berhad Cash Flow Statement
Financials in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 6.03 | 6.03 | 6.8 | 3.75 | 0.68 | -13.23 | Upgrade
|
| Depreciation & Amortization | 2.36 | 2.36 | 2.39 | 2.57 | 2.6 | 2.66 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.9 | -0.9 | 0.48 | -0.77 | -0.89 | -0.15 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.02 | 0.02 | -1.43 | 0.2 | 0.05 | 0.17 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | -0.18 | - | Upgrade
|
| Loss (Gain) on Equity Investments | 0.28 | 0.28 | 0.19 | 0 | - | - | Upgrade
|
| Stock-Based Compensation | - | - | - | 0.65 | - | 9.42 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.41 | 0.41 | -0.02 | 0.19 | -1.35 | -2.98 | Upgrade
|
| Other Operating Activities | 1.71 | 1.71 | 2.06 | 1.15 | 2.65 | 1.08 | Upgrade
|
| Change in Accounts Receivable | 0.9 | 0.9 | 0.43 | -41.37 | -18.96 | 10.9 | Upgrade
|
| Change in Inventory | 0.38 | 0.38 | 2.1 | 2.63 | -1.11 | -0.35 | Upgrade
|
| Change in Accounts Payable | -1.36 | -1.36 | -3.55 | -1.16 | 0.15 | -0.3 | Upgrade
|
| Operating Cash Flow | 9.82 | 9.82 | 9.43 | -32.15 | -16.36 | 7.2 | Upgrade
|
| Operating Cash Flow Growth | - | 4.21% | - | - | - | - | Upgrade
|
| Capital Expenditures | -0.62 | -0.62 | -0.57 | -2.19 | -2.4 | -1.16 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.65 | 0.65 | 1.13 | 1.21 | 14.13 | 0.04 | Upgrade
|
| Cash Acquisitions | - | - | - | - | 2.87 | - | Upgrade
|
| Divestitures | -0.02 | -0.02 | -0.04 | - | - | - | Upgrade
|
| Investment in Securities | -1.29 | -1.29 | -0.98 | -0 | 0.18 | - | Upgrade
|
| Other Investing Activities | 0.17 | 0.17 | 0.05 | 0.05 | 0.19 | 0.5 | Upgrade
|
| Investing Cash Flow | -1.11 | -1.11 | -0.41 | -0.93 | 14.98 | 0.93 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 0 | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | 2.16 | - | 0.12 | - | Upgrade
|
| Total Debt Issued | 1.44 | 1.44 | 2.16 | 0 | 0.12 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -3 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | -0.54 | -0.44 | -10.36 | -1.24 | Upgrade
|
| Total Debt Repaid | -0.67 | -0.67 | -0.54 | -0.44 | -13.36 | -1.24 | Upgrade
|
| Net Debt Issued (Repaid) | 0.77 | 0.77 | 1.62 | -0.44 | -13.24 | -1.24 | Upgrade
|
| Issuance of Common Stock | 1.03 | 1.03 | 0.04 | 1.22 | 23.15 | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | -2 | - | - | Upgrade
|
| Other Financing Activities | -0.3 | -0.3 | - | -0.78 | -0.25 | -0.62 | Upgrade
|
| Financing Cash Flow | 1.5 | 1.5 | 1.66 | -1.99 | 9.66 | -1.86 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.04 | 0.04 | 0.06 | 0.08 | 0 | -0.31 | Upgrade
|
| Net Cash Flow | 10.25 | 10.25 | 10.74 | -35 | 8.28 | 5.97 | Upgrade
|
| Free Cash Flow | 9.2 | 9.2 | 8.86 | -34.34 | -18.76 | 6.04 | Upgrade
|
| Free Cash Flow Growth | - | 3.86% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 9.67% | 9.67% | 9.03% | -35.37% | -20.73% | 7.35% | Upgrade
|
| Free Cash Flow Per Share | 0.01 | 0.01 | 0.01 | -0.04 | -0.03 | 0.01 | Upgrade
|
| Cash Interest Paid | 0.29 | 0.29 | 0.24 | 0.21 | 0.26 | 0.6 | Upgrade
|
| Cash Income Tax Paid | 3.88 | 3.88 | 3.51 | 2.65 | -0.15 | 0.32 | Upgrade
|
| Levered Free Cash Flow | - | - | 6.53 | -0.43 | 13.75 | -1.88 | Upgrade
|
| Unlevered Free Cash Flow | - | - | 6.69 | -0.3 | 13.91 | -1.5 | Upgrade
|
| Change in Net Working Capital | - | - | 2.77 | 6.23 | -11.25 | 4.8 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.